Evotec SE: Invitation to Conference Call

2 years ago

HAMBURG, GERMANY / ACCESSWIRE / January 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) is going…

Unleashing the Power of Exosomes for Early Disease Detection

2 years ago

By Paul R. Billings, M.D., Ph.D., CEO at Biological Dynamics, Inc. In today’s symptom-driven healthcare system, early stage disease can…

Revolutionizing Healthcare: Remedy- House Calls Unveils Groundbreaking Platform for On-Demand, Personalized Care

2 years ago

New York, NY - Remedy - House Calls, a cutting-edge healthcare technology platform, is set to transform the landscape of…

InkSpace Imaging Announces Dr. E. Brian Welch, PhD, MBA as Vice President of Clinical Partnerships

2 years ago

PLEASANTON, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging today announced the appointment of Dr. E. Brian Welch, PhD,…

Defence Financing

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - January 19, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the…

NuGen Receives Two Additional Sales Orders for InsuJet(TM) and Expands Distribution into Argentina, Chile, Costa Rica and Peru

2 years ago

Toronto, Ontario--(Newsfile Corp. - January 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading…

Registration Opens for 2024 Robotics Summit & Expo

2 years ago

Registration is now open for the Robotics Summit & Expo, the world’s leading technical event for commercial robotics developers. The…

Boosh Plant-Based Brands Inc. Provides a Corporate Update

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - January 19, 2024) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i)  ("Boosh" or the…

United Health Products Reports on FDA Application Status

2 years ago

MESQUITE, NV, Jan. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products (UEEC) reports today on the receipt and…

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

2 years ago

- 10,000-subject Phase 2b study would evaluate Vaxart’s next generation oral pill XBB COVID-19 vaccine against an approved mRNA vaccine…